A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients

Condition:   Steroid Dependent Crohn's Disease Interventions:   Drug: Cannabidiol , synthetic form;   Drug: Placebo Sponsor:   Stero Biotechs Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials